Cargando…

Gonadotrophin releasing hormone antagonist in IVF/ICSI

OBJECTIVE: To study the efficacy of gonadotrophin releasing hormone (GnRH) antagonist in In-vitro-fertilization/Intracytoplasmic sperm injection (IVF/ICSI) cycles. TYPE OF STUDY: Observational study. SETTING: Reproductive Medicine Unit, Christian Medical College Hospital, Vellore, Tamil Nadu. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales:	MS, Kamath, AM, Mangalraj, KM, Muthukumar, K, George
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700675/ https://www.ncbi.nlm.nih.gov/pubmed/19562061

Ejemplares similares

Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021)

Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK
por: Rosario, Derek J., et al.
Publicado: (2016)

Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
por: Zhu, Shaomi, et al.
Publicado: (2022)

Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles
por: Tandulwadkar, Sunita, et al.
Publicado: (2023)

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Broekmans, Frank, et al.
Publicado: (2021)

The Impact of Pituitary Blockage with GnRH Antagonist and Gonadotrophin Stimulation Length on The Outcome of ICSI Cycles in Women Older than 36 Years
por: Santana, Rosane, et al.
Publicado: (2014)

IVF or ICSI for fertility preservation?
por: Aggarwal, Bhorika, et al.
Publicado: (2021)

Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Piette, Paul C M
Publicado: (2021)

Prediction of ovarian response in IVF/ICSI cycles
por: Cortés-Vazquez, Alfredo, et al.
Publicado: (2021)

Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility
por: Wang, Yizhuo, et al.
Publicado: (2022)

Comparison of clinical outcomes between in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in IVF-ICSI split insemination cycles
por: Lee, Sun Hee, et al.
Publicado: (2017)

Blastocyst stage transfer vs cleavage stage embryo transfer
por: Mangalraj, Ann M, et al.
Publicado: (2009)

Optimisation of the follicular phase in IVF/ICSI
por: Blockeel, C.
Publicado: (2012)

The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization
por: Lee, Kyung-Hee, et al.
Publicado: (2014)

ESHRE guideline: ovarian stimulation for IVF/ICSI(†)
por: Bosch, Ernesto, et al.
Publicado: (2020)

The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve
por: Mahran, Ahmad, et al.
Publicado: (2021)

Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges
por: Ou, Jianping, et al.
Publicado: (2015)

Temporal and Spatial Regulation of CRE Recombinase Expression in Gonadotrophin-Releasing Hormone Neurones in the Mouse
por: Wolfe, A, et al.
Publicado: (2008)

Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
por: Xing, Weijie, et al.
Publicado: (2015)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI
por: Kim, Chung-Hoon, et al.
Publicado: (2011)

Evaluation of pretreatment with Cetrotide in an antagonist protocol for patients with PCOS undergoing IVF/ICSI cycles: a randomized clinical trial
por: Eftekhar, Maryam, et al.
Publicado: (2018)

Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI
por: Bosch, Ernesto, et al.
Publicado: (2020)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
por: Eftekhar, Maryam, et al.
Publicado: (2016)

Outcome of conventional IVF and ICSI on sibling oocytes in moderate ligoasthenozoospermia
por: Xie, Bao-Guo, et al.
Publicado: (2013)

Transport IVF-ICSI: Results of a 25-year experience
por: Raffo, Fernanda G.E., et al.
Publicado: (2018)

Can we predict the IVF/ICSI live birth rate?
por: Metello, José Luis, et al.
Publicado: (2019)

Accuracy of endometrial length measurement in predicting IVF/ICSI outcome
por: Nayyef, Shaymaa Abdul-Sattar, et al.
Publicado: (2022)

Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function
por: Armstrong, S.P., et al.
Publicado: (2011)

Sperm DNA damage and its role in IVF and ICSI
por: Bach, Phil Vu, et al.
Publicado: (2016)

The degree of serum estradiol decline in early and midluteal phase had no adverse effect on IVF/ICSI outcome
por: Narvekar, Sachin A, et al.
Publicado: (2010)

Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle
por: Liu, Xin, et al.
Publicado: (2022)

Comparison of Dydrogesterone and GnRH Antagonists for Prevention of Premature LH Surge in IVF/ICSI Cycles: A Randomized Controlled Trial
por: Hossein Rashidi, Batool, et al.
Publicado: (2020)

The Value of Automated Follicle Volume Measurements in IVF/ICSI
por: Vandekerckhove, Frank, et al.
Publicado: (2014)

Smoking Decreases Endometrial Thickness in IVF/ICSI Patients
por: Heger, Anna, et al.
Publicado: (2018)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k5n2dsu36bqqrka739m3lonr9h